AMEI's Current Trends in Diagnosis & Treatment

Register      Login

VOLUME 3 , ISSUE 2 ( July-December, 2019 ) > List of Articles

CASE REPORT

A Huge Retroperitoneal Liposarcoma: A Case Report

Rajat Sharma, Mohit Sharma, Sanchit Bansal, Karaninder Singh, Neeti R Singh

Keywords : Radical treatment, Retroperitoneal liposarcoma, Soft-tissue sarcomas,Myxoid areas

Citation Information : Sharma R, Sharma M, Bansal S, Singh K, Singh NR. A Huge Retroperitoneal Liposarcoma: A Case Report. Curr Trends Diagn Treat 2019; 3 (2):90-92.

DOI: 10.5005/jp-journals-10055-0077

License: CC BY-NC 4.0

Published Online: 18-07-2020

Copyright Statement:  Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim: Retroperitoneal soft-tissue sarcomas are relatively uncommon diseases, and the most frequent histotype, ranging from 20 to 45% of all cases, is represented by liposarcoma, which is a hard-to-treat condition for its local aggressiveness and clinical aspecificity. Presentation of case: We report a case of a 69-year-old woman who underwent surgical resection for a giant pleomorphic retroperitoneal liposarcoma. Discussion: Currently, chemotherapy for retroperitoneal soft-tissue sarcomas is not effective, and radiotherapy has limited efficacy due to the toxicity affecting adjacent intra-abdominal structures and showed validity only in case of high-grade malignancy by reducing local recurrence but with no advantage in overall survival. Nowadays, complete surgical resection remains the most important predictor of local recurrence and overall survival. Conclusion: The removal of a retroperitoneal sarcoma of remarkable size is a challenge for the surgeon owing to the anatomical site, the absence of an anatomically evident vascular-lymphatic peduncle, and the adhesions contracted with the contiguous organs and great vessels. Therefore, we believe that, particularly for large-sized diseases associated with high-grade malignancy, a complete surgical resection with the removal of the contiguous intra- and retroperitoneal organs when infiltrated represents the only therapeutic option to obtain a negative margin and therefore an oncological radicality.


PDF Share
  1. Leao P, Vilaça S, Oliveira M, et al. Giant recurrent retroperitoneal liposarcoma initially presenting as inguinal hernia: review of literature. Int J Surg Case Rep 2012;3(3):103–106. DOI: 10.1016/j.ijscr.2011.03.009.
  2. Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998;228(3):355–365. DOI: 10.1097/00000658-199809000-00008.
  3. Hashimoto Y, Hatakeyama S, Tachiwada T. Surgical treatment of a giant liposarcoma in a Japanese man. Adv Urol 2010. DOI: 10.1155/2010/943073.
  4. Martínez León MI, Martos Forniels JA, Arranz Salas IM, et al. Liposarcoma of the perirenal cell. Arch Esp Urol 2003;56(9):1050–1054.
  5. Crago AM, Singer S. Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma. Curr Opin Oncol 2011;23(4):373–378. DOI: 10.1097/CCO.0b013e32834796e6.
  6. Fletcher C, Unni K, Mertens F. Pathology and genetics of tumors of soft tissue and bone. In: Kleihues P. World Health Organization Classification of Tumors. Lyon: International Agency for Research on Cancer Press; 2002.
  7. Singer S, Antonescu CR, Riedel E, et al. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 2003;238(3):358–370. DOI: 10.1097/01.sla.0000086542.11899.38.
  8. Grasso E, Marino F, Bottalico M, et al. A case of myxoid liposarcoma of the retroperitoneum: a challenging tumour for diagnosis and treatment. Case Rep Surg 2014;2014:572805. DOI: 10.1155/2014/572805.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.